# James L. Gulley

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-l-gulley/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,389 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 89 |
| i10-index | 372 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5070669850 |
| ORCID iD | https://orcid.org/0000-0002-6569-2912 |
| Works | 983 |

## Researcher papers

- [Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial](https://scholariq.org/papers/avelumab-for-metastatic-or-locally-advanced-previously-treated-solid-tumours/)
- [Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial](https://scholariq.org/papers/avelumab-for-patients-with-previously-treated-metastatic-or-recurrent-non-small/)
- [Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy](https://scholariq.org/papers/sicca-syndrome-associated-with-immune-checkpoint-inhibitor-therapy/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.